RBC Capital Maintains Outperform on Danaher, Raises Price Target to $250
10/5/2026
Impact: 75
Healthcare
RBC Capital analyst Dan Leonard has maintained an Outperform rating on Danaher (NYSE: DHR) and raised the price target from $215 to $250. This adjustment reflects a positive outlook on the company's performance.
AI summary, not financial advice
Share: